Mail

Canada markets open in 31 minutes

S&P/TSX
21,885.38
+11.66(+0.05%)
S&P 500
5,048.42
-23.21(-0.46%)
DOW
38,085.80
-375.12(-0.98%)
CAD/USD
0.7325
+0.0002(+0.02%)
CRUDE OIL
84.22
+0.65(+0.78%)
Bitcoin CAD
87,469.05
+926.70(+1.07%)

MARKETS LIVE BLOG

STOCK FUTURES JUMP, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

1.3500

+0.0500

(+3.85%)

At close: 03:53PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	33.18M
Enterprise Value	77.26M
Trailing P/E	4.66
Forward P/E	7.50
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.25
Price/Book (mrq)	1.12
Enterprise Value/Revenue	0.67
Enterprise Value/EBITDA	3.92

Trading Information

Stock Price History

Beta (5Y Monthly)	1.85
52-Week Change ³	40.19%
S&P500 52-Week Change ³	21.08%
52 Week High ³	2.5620
52 Week Low ³	0.8380
50-Day Moving Average ³	1.2192
200-Day Moving Average ³	1.6415

Share Statistics

Avg Vol (3 month) ³	19k
Avg Vol (10 day) ³	20.33k
Shares Outstanding ⁵	24.46M
Implied Shares Outstanding ⁶	24.58M
Float ⁸	20.59M
% Held by Insiders ¹	8.69%
% Held by Institutions ¹	11.35%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Dec 19, 2018
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Mar 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	5.08%
Operating Margin (ttm)	6.22%

Management Effectiveness

Return on Assets (ttm)	5.21%
Return on Equity (ttm)	26.14%

Income Statement

Revenue (ttm)	115.72M
Revenue Per Share (ttm)	5.46
Quarterly Revenue Growth (yoy)	-12.30%
Gross Profit (ttm)	N/A
EBITDA	18.32M
Net Income Avi to Common (ttm)	5.88M
Diluted EPS (ttm)	0.2900
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	8.21M
Total Cash Per Share (mrq)	0.34
Total Debt (mrq)	52.29M
Total Debt/Equity (mrq)	176.88%
Current Ratio (mrq)	1.11
Book Value Per Share (mrq)	1.21

Cash Flow Statement

Operating Cash Flow (ttm)	20.97M
Levered Free Cash Flow (ttm)	8.24M